silver has been researched along with ro13-9904 in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Arthanareeswaran, G; Harshiny, M; Kumaran, S; Matheswaran, M; Rajasree, S | 1 |
Gholipourmalekabadi, M; Hashemi, A; Mozafari, M; Rostami, A; Sameni, M; Zamani, F | 1 |
Kumar, SS; MubarakAli, D; Muthukumar, H; Prabakar, D; Pugazhendhi, A; Shanmuganathan, R; Thajuddin, N | 1 |
Goryacheva, IY; Markin, AV; Markina, NE | 1 |
Buzulukov, YP; Chestnova, TV; Gladkikh, PG; Khadartsev, AA; Korotkova, AS; Zilov, VG | 1 |
Elsebaei, F; Metwally, ME; Mostafa, YE | 1 |
6 other study(ies) available for silver and ro13-9904
Article | Year |
---|---|
Enhancement of antibacterial properties of silver nanoparticles-ceftriaxone conjugate through Mukia maderaspatana leaf extract mediated synthesis.
Topics: Anti-Bacterial Agents; Antioxidants; Ceftriaxone; Cucumis; Green Chemistry Technology; Klebsiella pneumoniae; Metal Nanoparticles; Microscopy, Electron, Transmission; Nanoconjugates; Plant Extracts; Plant Leaves; Pseudomonas fluorescens; Silver; Silver Nitrate; Spectroscopy, Fourier Transform Infrared; Staphylococcus aureus | 2015 |
Silver- and fluoride-containing mesoporous bioactive glasses versus commonly used antibiotics: Activity against multidrug-resistant bacterial strains isolated from patients with burns.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Aztreonam; Burns; Carbenicillin; Cefepime; Ceftazidime; Ceftriaxone; Cell Survival; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluorides; Gentamicins; Glass; Humans; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; NIH 3T3 Cells; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Silver; Thienamycins; Tobramycin; Wound Infection | 2016 |
An enhancement of antimicrobial efficacy of biogenic and ceftriaxone-conjugated silver nanoparticles: green approach.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacillus cereus; Ceftriaxone; Humans; Klebsiella pneumoniae; Metal Nanoparticles; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Silver; Staphylococcus aureus | 2018 |
Sample pretreatment and SERS-based detection of ceftriaxone in urine.
Topics: Anti-Bacterial Agents; Ceftriaxone; Drug Monitoring; Humans; Hydrogen-Ion Concentration; Hydroxylamine; Limit of Detection; Metal Nanoparticles; Models, Molecular; Silica Gel; Silver; Spectrum Analysis, Raman | 2018 |
Combined Effect of Silver Nanoparticles, Ceftriaxone, and Methyluracil during Experimental Purulent Peritonitis.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Ceftriaxone; Infectious Disease Medicine; Inflammation; Male; Meningoencephalitis; Metal Nanoparticles; Peritonitis; Rats; Rats, Wistar; Recurrence; Silver; Uracil | 2018 |
Exploring fluorescence of metal nanoparticles for effective utility in drug sensing: A Promising ''on-off'' fluorescence probe for analysis of cephalosporins is fabricated.
Topics: Cefepime; Ceftriaxone; Cephalosporins; Fluorescent Dyes; Metal Nanoparticles; Silver; Spectrometry, Fluorescence | 2023 |